对患有心房或静脉血栓塞栓症的成年人服用口服抗凝药
Paul Kl Chin1,2, Matthew P Doogue1,2
1Department of Clinical Pharmacology, Christchurch Hospital, Health New Zealand, New Zealand.
Australian prescriber
|October 30, 2025
概括
直接作用的口服抗凝剂 (DOAC),如阿皮克萨班,里瓦罗克萨班和达比加特兰,对非膜性心房动 (AF) 和静脉血栓塞栓症 (VTE) 有效. 虽然在没有常规监测的情况下通常是安全的,但在特定情况下可能需要调整剂量和测试.
科学领域:
- 药理学 药理学是指药理学的学科.
- 心脏病学 心脏病学
- 血液学 血液学 血液学
背景情况:
- 直接作用的口服抗凝剂 (DOAC) 是抗凝剂治疗的重大进展.
- 目前的DOAC包括阿皮克萨班,里瓦罗克萨班和达比加特兰,为华法林提供了替代品.
- 特定的患者群体,如患有膜AF,机械心脏门或与癌症相关的VTE患者,有不同的一线治疗建议.
研究的目的:
- 概述在患有非膜性心房动 (AF) 和静脉血栓塞栓症 (VTE) 的患者中适当使用DOAC.
- 突出特定的临床场景,其中DOACs是首选的或需要剂量调整.
- 讨论实验室监测在DOAC治疗中的作用.
主要方法:
- 审查当前的临床指导方针和有关DOAC使用的证据.
- 患者群体和条件的识别,其中DOACs是适用的.
- 对影响DOAC剂量和实验室监测必要性的因素的分析.
主要成果:
- DOAC适用于大多数非膜AF或VTE患者.
- 华法林仍然是膜AF与机械心脏门或类风性心肌狭窄症的第一线治疗.
- 阿皮克萨班和里瓦罗克萨班在与癌症相关的静脉瘤和肥胖患者 (BMI>35 kg/m2或体重>120 kg) 中是首选药物.
- 对于中度功能障碍患者,对DOACs的剂量调整是必要的.
- 通常不需要对DOAC进行例行实验室监测,但在紧急情况或怀疑不充分/过度抗凝剂等特定情况下是有益的.
结论:
- DOACs为AF和VTE管理提供了广泛的治疗窗口.
- 个性化治疗决策至关重要,考虑到患者特定的因素,如膜状况,恶性瘤,肥胖和功能.
- 虽然常规监测不是标准,但有针对性的实验室评估可以帮助管理复杂的临床情景和潜在的并发症.
相关概念视频
Venous Thrombosis III: Interprofessional Care
273
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
273
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
2.1K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
2.1K
Anticoagulant Drugs: Low-Molecular-Weight Heparins
1.6K
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
1.6K
Venous Thrombosis IV: Nursing Management
191
Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
191
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
298
Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
298
Venous Thrombosis I: Introduction
335
Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
335


